TLR9 ligation in pancreatic stellate cells promotes tumorigenesis

Constantinos P. Zambirinis, Elliot Levie, Susanna Nguy, Antonina Avanzi, Rocky Barilla, Yijie Xu, Lena Seifert, Donnele Daley, Stephanie H. Greco, Michael Deutsch, Saikiran Jonnadula, Alejandro Torres-Hernandez, Daniel Tippens, Smruti Pushalkar, Andrew Eisenthal, Deepak Saxena, Jiyoung Ahn, Cristina Hajdu, Dannielle D. Engle, David TuvesonGeorge Miller

Research output: Contribution to journalArticle

Abstract

Modulation of Toll-like receptor (TLR) signaling can have protective or protumorigenic effects on oncogenesis depending on the cancer subtype and on specific inflammatory elements within the tumor milieu. We found that TLR9 is widely expressed early during the course of pancreatic transformation and that TLR9 ligands are ubiquitous within the tumor microenvironment. TLR9 ligation markedly accelerates oncogenesis, whereas TLR9 deletion is protective. We show that TLR9 activation has distinct effects on the epithelial, inflammatory, and fibrogenic cellular subsets in pancreatic carcinoma and plays a central role in cross talk between these compartments. Specifically, TLR9 activation can induce proinflammatory signaling in transformed epithelial cells, but does not elicit oncogene expression or cancer cell proliferation. Conversely, TLR9 ligation induces pancreatic stellate cells (PSCs) to become fibrogenic and secrete chemokines that promote epithelial cell proliferation. TLR9-activated PSCs mediate their protumorigenic effects on the epithelial compartment via CCL11. Additionally, TLR9 has immune-suppressive effects in the tumor microenvironment (TME) via induction of regulatory T cell recruitment and myeloid- derived suppressor cell proliferation. Collectively, our work shows that TLR9 has protumorigenic effects in pancreatic carcinoma which are distinct from its influence in extrapancreatic malignancies and from the mechanistic effects of other TLRs on pancreatic oncogenesis.

Original languageEnglish (US)
Pages (from-to)2077-2094
Number of pages18
JournalJournal of Experimental Medicine
Volume212
Issue number12
DOIs
StatePublished - 2015

Fingerprint

Pancreatic Stellate Cells
Ligation
Carcinogenesis
Tumor Microenvironment
Cell Proliferation
Neoplasms
Epithelial Cells
Toll-Like Receptors
Regulatory T-Lymphocytes
Oncogenes
Chemokines
Ligands

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Zambirinis, C. P., Levie, E., Nguy, S., Avanzi, A., Barilla, R., Xu, Y., ... Miller, G. (2015). TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. Journal of Experimental Medicine, 212(12), 2077-2094. https://doi.org/10.1084/jem.20142162

TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. / Zambirinis, Constantinos P.; Levie, Elliot; Nguy, Susanna; Avanzi, Antonina; Barilla, Rocky; Xu, Yijie; Seifert, Lena; Daley, Donnele; Greco, Stephanie H.; Deutsch, Michael; Jonnadula, Saikiran; Torres-Hernandez, Alejandro; Tippens, Daniel; Pushalkar, Smruti; Eisenthal, Andrew; Saxena, Deepak; Ahn, Jiyoung; Hajdu, Cristina; Engle, Dannielle D.; Tuveson, David; Miller, George.

In: Journal of Experimental Medicine, Vol. 212, No. 12, 2015, p. 2077-2094.

Research output: Contribution to journalArticle

Zambirinis, CP, Levie, E, Nguy, S, Avanzi, A, Barilla, R, Xu, Y, Seifert, L, Daley, D, Greco, SH, Deutsch, M, Jonnadula, S, Torres-Hernandez, A, Tippens, D, Pushalkar, S, Eisenthal, A, Saxena, D, Ahn, J, Hajdu, C, Engle, DD, Tuveson, D & Miller, G 2015, 'TLR9 ligation in pancreatic stellate cells promotes tumorigenesis', Journal of Experimental Medicine, vol. 212, no. 12, pp. 2077-2094. https://doi.org/10.1084/jem.20142162
Zambirinis CP, Levie E, Nguy S, Avanzi A, Barilla R, Xu Y et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. Journal of Experimental Medicine. 2015;212(12):2077-2094. https://doi.org/10.1084/jem.20142162
Zambirinis, Constantinos P. ; Levie, Elliot ; Nguy, Susanna ; Avanzi, Antonina ; Barilla, Rocky ; Xu, Yijie ; Seifert, Lena ; Daley, Donnele ; Greco, Stephanie H. ; Deutsch, Michael ; Jonnadula, Saikiran ; Torres-Hernandez, Alejandro ; Tippens, Daniel ; Pushalkar, Smruti ; Eisenthal, Andrew ; Saxena, Deepak ; Ahn, Jiyoung ; Hajdu, Cristina ; Engle, Dannielle D. ; Tuveson, David ; Miller, George. / TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. In: Journal of Experimental Medicine. 2015 ; Vol. 212, No. 12. pp. 2077-2094.
@article{e7020696c0d1455ba0cce9b02242dcb7,
title = "TLR9 ligation in pancreatic stellate cells promotes tumorigenesis",
abstract = "Modulation of Toll-like receptor (TLR) signaling can have protective or protumorigenic effects on oncogenesis depending on the cancer subtype and on specific inflammatory elements within the tumor milieu. We found that TLR9 is widely expressed early during the course of pancreatic transformation and that TLR9 ligands are ubiquitous within the tumor microenvironment. TLR9 ligation markedly accelerates oncogenesis, whereas TLR9 deletion is protective. We show that TLR9 activation has distinct effects on the epithelial, inflammatory, and fibrogenic cellular subsets in pancreatic carcinoma and plays a central role in cross talk between these compartments. Specifically, TLR9 activation can induce proinflammatory signaling in transformed epithelial cells, but does not elicit oncogene expression or cancer cell proliferation. Conversely, TLR9 ligation induces pancreatic stellate cells (PSCs) to become fibrogenic and secrete chemokines that promote epithelial cell proliferation. TLR9-activated PSCs mediate their protumorigenic effects on the epithelial compartment via CCL11. Additionally, TLR9 has immune-suppressive effects in the tumor microenvironment (TME) via induction of regulatory T cell recruitment and myeloid- derived suppressor cell proliferation. Collectively, our work shows that TLR9 has protumorigenic effects in pancreatic carcinoma which are distinct from its influence in extrapancreatic malignancies and from the mechanistic effects of other TLRs on pancreatic oncogenesis.",
author = "Zambirinis, {Constantinos P.} and Elliot Levie and Susanna Nguy and Antonina Avanzi and Rocky Barilla and Yijie Xu and Lena Seifert and Donnele Daley and Greco, {Stephanie H.} and Michael Deutsch and Saikiran Jonnadula and Alejandro Torres-Hernandez and Daniel Tippens and Smruti Pushalkar and Andrew Eisenthal and Deepak Saxena and Jiyoung Ahn and Cristina Hajdu and Engle, {Dannielle D.} and David Tuveson and George Miller",
year = "2015",
doi = "10.1084/jem.20142162",
language = "English (US)",
volume = "212",
pages = "2077--2094",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "12",

}

TY - JOUR

T1 - TLR9 ligation in pancreatic stellate cells promotes tumorigenesis

AU - Zambirinis, Constantinos P.

AU - Levie, Elliot

AU - Nguy, Susanna

AU - Avanzi, Antonina

AU - Barilla, Rocky

AU - Xu, Yijie

AU - Seifert, Lena

AU - Daley, Donnele

AU - Greco, Stephanie H.

AU - Deutsch, Michael

AU - Jonnadula, Saikiran

AU - Torres-Hernandez, Alejandro

AU - Tippens, Daniel

AU - Pushalkar, Smruti

AU - Eisenthal, Andrew

AU - Saxena, Deepak

AU - Ahn, Jiyoung

AU - Hajdu, Cristina

AU - Engle, Dannielle D.

AU - Tuveson, David

AU - Miller, George

PY - 2015

Y1 - 2015

N2 - Modulation of Toll-like receptor (TLR) signaling can have protective or protumorigenic effects on oncogenesis depending on the cancer subtype and on specific inflammatory elements within the tumor milieu. We found that TLR9 is widely expressed early during the course of pancreatic transformation and that TLR9 ligands are ubiquitous within the tumor microenvironment. TLR9 ligation markedly accelerates oncogenesis, whereas TLR9 deletion is protective. We show that TLR9 activation has distinct effects on the epithelial, inflammatory, and fibrogenic cellular subsets in pancreatic carcinoma and plays a central role in cross talk between these compartments. Specifically, TLR9 activation can induce proinflammatory signaling in transformed epithelial cells, but does not elicit oncogene expression or cancer cell proliferation. Conversely, TLR9 ligation induces pancreatic stellate cells (PSCs) to become fibrogenic and secrete chemokines that promote epithelial cell proliferation. TLR9-activated PSCs mediate their protumorigenic effects on the epithelial compartment via CCL11. Additionally, TLR9 has immune-suppressive effects in the tumor microenvironment (TME) via induction of regulatory T cell recruitment and myeloid- derived suppressor cell proliferation. Collectively, our work shows that TLR9 has protumorigenic effects in pancreatic carcinoma which are distinct from its influence in extrapancreatic malignancies and from the mechanistic effects of other TLRs on pancreatic oncogenesis.

AB - Modulation of Toll-like receptor (TLR) signaling can have protective or protumorigenic effects on oncogenesis depending on the cancer subtype and on specific inflammatory elements within the tumor milieu. We found that TLR9 is widely expressed early during the course of pancreatic transformation and that TLR9 ligands are ubiquitous within the tumor microenvironment. TLR9 ligation markedly accelerates oncogenesis, whereas TLR9 deletion is protective. We show that TLR9 activation has distinct effects on the epithelial, inflammatory, and fibrogenic cellular subsets in pancreatic carcinoma and plays a central role in cross talk between these compartments. Specifically, TLR9 activation can induce proinflammatory signaling in transformed epithelial cells, but does not elicit oncogene expression or cancer cell proliferation. Conversely, TLR9 ligation induces pancreatic stellate cells (PSCs) to become fibrogenic and secrete chemokines that promote epithelial cell proliferation. TLR9-activated PSCs mediate their protumorigenic effects on the epithelial compartment via CCL11. Additionally, TLR9 has immune-suppressive effects in the tumor microenvironment (TME) via induction of regulatory T cell recruitment and myeloid- derived suppressor cell proliferation. Collectively, our work shows that TLR9 has protumorigenic effects in pancreatic carcinoma which are distinct from its influence in extrapancreatic malignancies and from the mechanistic effects of other TLRs on pancreatic oncogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84964391958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964391958&partnerID=8YFLogxK

U2 - 10.1084/jem.20142162

DO - 10.1084/jem.20142162

M3 - Article

C2 - 26481685

AN - SCOPUS:84964391958

VL - 212

SP - 2077

EP - 2094

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 12

ER -